CellaVision AB (publ) develops and sells instruments, software, and reagents for blood and body fluids analysis in Sweden and internationally. The company provides digital hematology microscopy solutions, covering analyzers and instruments; and hardware products, including in vitro diagnostics IVD for laboratories; smear makers, stainers, stains, and staining protocols; DIFF-Line, a hematology lab that handles a smaller amount daily blood samples, as well as consists of three instruments, such as CellaVision DC-1, RAL SmearBox, and RAL StainBox for smearing, staining, and analyzing peripheral blood smears. It also provides CellaVision DC-1 for performing blood cell differentials; and CellaVision DM1200 and CellaVision DM9600 to automate and simplify the process of performing blood and body fluid differentials. In addition, the company's CellaVision Peripheral Blood Application enables laboratories to automate, standardize and simplify morphological examination like peripheral blood smears; CellaVision Advanced RBC Application performs a more comprehensive examination for red blood cell morphology; CellaVision Body Fluid Application is for examination body fluid preparations; CellaVision CellAtlas is an app with morphology experts for series mini lectures on extensive cell image library introduction to cell morphology; CellaVision Remote Review Software removes restrictive geographical constraints from smear review process and performs better; CellaVision Server Software creates a single streamlined workflow within one or multiple testing sites; and CellaVision VET is a veterinary lab. It sells its products to hospitals and commercial laboratories. The company was incorporated in 1994 and is based in Lund, Sweden.
Show more...
CEO
Mr. Christer Fahraeus B.Sc. Maths, h.c., MSc Bio Eng, Ph.D.
The current price of CVLLY is $9.04 USD — it has increased by +3.31% in the past 24 hours. Watch Cellavision AB stock price performance more closely on the chart.
What is Cellavision AB stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cellavision AB stocks are traded under the ticker CVLLY.
What is Cellavision AB market cap?▼
Today Cellavision AB has the market capitalization of 215.62M
When is the next Cellavision AB earnings date?▼
Cellavision AB is going to release the next earnings report on April 24, 2026.
What were Cellavision AB earnings last quarter?▼
CVLLY earnings for the last quarter are 0.19 USD per share, whereas the estimation was 0.14 USD resulting in a +37.28% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cellavision AB revenue for the last year?▼
Cellavision AB revenue for the last year amounts to 131.24M USD.
What is Cellavision AB net income for the last year?▼
CVLLY net income for the last year is 25.53M USD.
How many employees does Cellavision AB have?▼
As of April 01, 2026, the company has 229 employees.
In which sector is Cellavision AB located?▼
Cellavision AB operates in the Industrials sector.
When did Cellavision AB complete a stock split?▼
Cellavision AB has not had any recent stock splits.